Looking to publish in Journal of Antimicrobial Chemotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginJournal of Antimicrobial Chemotherapy is the flagship journal of the British Society for Antimicrobial Chemotherapy and publishes research in antimicrobial chemotherapy, infectious diseases, medical microbiology, and related therapeutics. It is published by Oxford University Press and offers optional open access publishing alongside subscription access.
Looking to publish in Journal of Antimicrobial Chemotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Journal of Antimicrobial Chemotherapy accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Systematic Review Articles
Review Articles
Brief Reports
Correspondence
Case Reports
Guidelines
Recent Publications
Oritavancin for infective endocarditis: a systematic review of effectiveness, safety and dosing strategies
Panagiotis Giouglis, Sofia Adali, Vasilios Petrakis, Rozeta Sokou, Konstantina A Tsante, Petros Ioannou, Sotirios P Fortis, Alexandra Mpakosi, Deny Tsakri, Aikaterini I Liakou, Georgia Vrioni, George Samonis, Stefanos Bonovas, Gerasimos Siasos, Andreas G Tsantes
Synergistic antibacterial effect and improved pharmacokinetics of florfenicol in combination with sulfamonomethoxine sodium
Xiaoyang Ai, Jinping Lan, Nanxin Li, Yixing Chen, Lian Chen, Wei Zhang, Gang Shu, Juchun Lin, Haohuan Li, Funeng Xu, Hualin Fu
Changes in sales of medically important antimicrobials for use in livestock animals in Canada following the 2018 federal policy mandating veterinarian prescription
Fiona Emdin, E Jane Parmley, Kevin A Brown, Angelina L Bosman, Carolee A Carson, Valerie Leung, Bradley J Langford, Kevin L Schwartz, Nick Daneman
Antimicrobial resistance of Shigella spp. in South Australia and its detection using WGS
Helena Torpy, Arshdeep Kaur Mudhar, Lex E X Leong, Casey Moore, Helen Hocking, Emily Rowe, Lito E Papanicolas
Antimicrobial-resistant Pseudomonas aeruginosa in the USA: implications of a national surveillance gap
Richard R Watkins, Tracy L Lemonovich, Robert A Bonomo
Frequently asked questions
How long does it take to publish?
14 days to first decision; 14 days in review; 18 days from acceptance to advance access publication
Reformat to Journal of Antimicrobial Chemotherapy using Livewrite PremiumIs a cover letter required?
A covering letter is required. It must declare any previous publication of the material, including abstracts in conference proceedings or posters and clinical trials results databases, include details of any previous submission of the work to the journal that was rejected, and identify important in-press or submitted papers uploaded with the submission. Use of LLM tools must be noted in the cover letter. If prior publication of trial data in results databases exists, this must be declared in the covering letter.
Reformat to Journal of Antimicrobial Chemotherapy using Livewrite PremiumWhat are the publication costs?
Hybrid model. Authors may publish under standard subscription access at no charge, or choose open access for a charge. Viewpoints are made freely available online immediately upon publication free of charge.
Reformat to Journal of Antimicrobial Chemotherapy using Livewrite Premium